William Blair Upgrades Infinity Pharmaceutical (INFI) to Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/23/2026
- Wall St futures ease as Big Tech earnings rekindle AI spending worries, oil jumps
- Google increases capex forecast again after cloud-driven quarterly beat
- As Musk pivots beyond cars, Tesla’s autos engine is under strain
- RTX stock jumps as company lifts guidance after Q2 beat
- Dollar hits fresh 40-year high versus yen, edges higher against euro
Infinity Pharmaceuticals, Inc. (INFI) Tops Q1 EPS by 6c
August 5, 2014 8:14 AM EDTInfinity Pharmaceuticals, Inc. (NASDAQ: INFI) reported Q1 EPS of ($0.78), $0.06 better than the analyst estimate of ($0.84).
For earnings history and earnings-related data on Infinity Pharmaceuticals, Inc. (INFI) click here.
... More